Danaher acquires Life Technologies' mass spectrometry business

Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation (NYSE: DHR) for $450 million in cash, subject to a conventional working capital adjustment.

Danaher has also acquired Life Technologies’ joint venture partner in the business, MDS Analytical Technologies, a division of MDS Inc. (NYSE: MDZ). Mass spectrometers are highly sensitive and sophisticated instruments used by researchers and clinicians to identify and quantify specific molecules in complex samples.

As previously announced, Life Technologies does not expect the sale of its mass spectrometry business to affect its previously announced 2009 and 2010 earnings expectations.

Source: Life Technologies Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Danaher. (2010, February 02). Danaher acquires Life Technologies' mass spectrometry business. News-Medical. Retrieved on April 13, 2024 from https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx.

  • MLA

    Danaher. "Danaher acquires Life Technologies' mass spectrometry business". News-Medical. 13 April 2024. <https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx>.

  • Chicago

    Danaher. "Danaher acquires Life Technologies' mass spectrometry business". News-Medical. https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx. (accessed April 13, 2024).

  • Harvard

    Danaher. 2010. Danaher acquires Life Technologies' mass spectrometry business. News-Medical, viewed 13 April 2024, https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Danaher offers GBP 50 million pounds for Genetix Group acquisition